COVID-19: the vasculature unleashed
Reply 8 people found this helpful
Just as when you first started GLP-1 therapy, each dose increase carries a risk of transient nausea or GI disruption Weight loss resumes
Overall, her research suggests that tirzepatide increased insulin sensitivity both independently and as a function of weight
However, stacking two medications of the same class requires careful medical supervision, as additive effects on appetite, nausea, and gastric motility can occur
Overall, when used in appropriate patients under medical supervision, sermorelin is typically well tolerated, and serious adverse effects are rare